Louisiana Cites New Filings To Support Mifepristone Appeal In 5th Circuit
NEW ORLEANS — Louisiana submitted a letter to the Fifth Circuit U.S. Court of Appeals after it heard oral argument in a case disputing whether the U.S. Food and Drug Administration’s...To view the full article, register now.
Already a subscriber? Click here to view full article